SOPHiA GENETICS SA
SOPH • NASDAQ
SOPHiA GENETICS SA is a medical - healthcare information services company in the healthcare sector trading on NASDAQ, led by CEO Jurgi Camblong, with a market cap of $339.0M.
Market Cap$339.0M
Employees449.0
CEOJurgi Camblong
CountrySwitzerland
Healthcare
Medical - Healthcare Information Services
Next EarningsMay 5, 2026 · In 3 weeksQ1 2026
Financials
SOPHiA GENETICS SA FAQ
Common questions about SOPHiA GENETICS SA
SOPHiA GENETICS SA is scheduled to report earnings for Q1 2026 on May 5, 2026. Analysts estimate revenue of $20.4M.
SOPHiA GENETICS SA has approximately 449 employees.